Trial Profile
Observational study of Vedolizumab for intestinal bowel disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2018
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 27 Nov 2018 New trial record
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting